1. Home
  2. BNGO

as 11-21-2024 3:32pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Industrials

Biotechnology: Laboratory Analytical Instruments

Nasdaq

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.

Founded: 2003 Country:
United States
United States
Employees: N/A City: SAN DIEGO
Market Cap: 28.7M IPO Year: 2018
Target Price: $1.00 AVG Volume (30 days): 3.5M
Analyst Decision: Hold Number of Analysts: 3
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.92 EPS Growth: N/A
52 Week Low/High: $0.20 - $2.27 Next Earning Date: 11-13-2024
Revenue: $33,334,000 Revenue Growth: -0.82%
Revenue Growth (this year): -0.09% Revenue Growth (next year): 21.35%

BNGO Daily Stock ML Predictions

Share on Social Networks: